Puerto Rico vs Saint Martin (French Part): Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Puerto Rico
0.2%
in 2024
Saint Martin (French Part)
0.2%
in 2024
Puerto Rico rank
98th
Saint Martin (French Part) rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Puerto Rico
- Saint Martin (French Part)
How they compare
Puerto Rico currently reports 0.2% against 0.2% in Saint Martin (French Part), a difference of 0.0%.
Across all 10 years both countries report, Saint Martin (French Part) has been ahead every year.
Puerto Rico ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
Head to head by decade
| Decade | Puerto Rico | Saint Martin (French Part) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.0% | — |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Puerto Rico or Saint Martin (French Part)?
- Puerto Rico, at 0.2% against 0.2% in Saint Martin (French Part) as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Puerto Rico and Saint Martin (French Part)?
- 0.0%, with Puerto Rico ahead.
- How many years of comparable data are there for Puerto Rico and Saint Martin (French Part)?
- 10 years are reported by both, from 2015 to 2024.
- How do Puerto Rico and Saint Martin (French Part) rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Puerto Rico ranks 98th and Saint Martin (French Part) ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.